Literature DB >> 20145394

Interstitial pneumonitis after treatment with bevacizumab and pegylated liposomal doxorubicin in a patient with metastatic breast cancer.

Jens Huober, Otto Schoch, Arnoud Templeton, Christian Spirig, Beat Thürlimann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20145394     DOI: 10.1159/000282286

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


× No keyword cloud information.
  6 in total

1.  Fatal pneumonitis after treatment with pegylated liposomal doxorubicin in a patient with metastatic breast cancer in complete remission.

Authors:  Michael Mark; Beat Thürlimann
Journal:  Med Oncol       Date:  2012-09       Impact factor: 3.064

2.  Interstitial pneumonitis induced by pegylated liposomal doxorubicin in a patient with recurrent ovarian cancer.

Authors:  Kanako Inaba; Takahide Arimoto; Mari Hoya; Kei Kawana; Shunsuke Nakagawa; Shiro Kozuma; Yuji Taketani
Journal:  Med Oncol       Date:  2011-03-10       Impact factor: 3.064

3.  Interstitial pneumonia during bevacizumab-based chemotherapy for colorectal cancer.

Authors:  Shingo Tamura; Hitoshi Kusaba; Naoki Kubo; Kayo Ijichi; Kenji Tsuchihashi; Masato Komoda; Keita Uchino; Hiroshi Ariyama; Koichi Akashi; Eishi Baba
Journal:  Med Oncol       Date:  2014-01-30       Impact factor: 3.064

4.  Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous Angiosarcoma.

Authors:  Marco Mazzotta; Raffaele Giusti; Daniela Iacono; Salvatore Lauro; Paolo Marchetti
Journal:  Case Rep Oncol Med       Date:  2016-01-20

5.  Bevacizumab-Induced Pneumonitis in a Patient With Metastatic Colon Cancer: A Case Report.

Authors:  Sami Pervaiz; Sylvester Homsy; Naureen Narula; Sam Ngu; Dany Elsayegh
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2020-06-15

6.  Drug-Induced Interstitial Lung Disease after Anthracycline-Combined Chemotherapy for Breast Cancer: A Case Report and Literature Review.

Authors:  Hideko Hoshina; Hiroyuki Takei
Journal:  Case Rep Oncol       Date:  2021-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.